1/44
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Inhibits T-lymphocyte and B-lymphocyte proliferation by altering nucleotide (purine) synthesis
Mycophenolate MOA
Thiopurine methyltransferase activity; low or absent activity of the anzyme can lead to severe, life-threatening myelosuppression
What test should patients undergo when prescribed axathioprine?
A monoclonal antibody that binds to the CD52 receptor on T-lymphocytes, leading to T-lymphocyte depletion
Alemtuzumab MOA
Polyclonal antibodies that bind to antigens on T-lymphocytes, leading to T-lymphocyte depletion
Antithymocyte globulin MOA
A monoclonal antibody that binds to the IL-2 receptor on the surface of activated T-lymphocytes, inhibiting proliferation
Basiliximab MOA
Age-appropriate cancer screening as part of transplant candidate work-up
Recommendations for reducing skin cancer in transplant recipients pre-treatment
Seek shade during peak sunlight hours, wear long-sleeve shirt, use broad-spectrum sunscreen SPF ≥30 (apply 15-30 min before sun exposure & reapply every 2 hours), wear a hat with ≥2” brim, wear sunglasses to protect skin around the eyes, have professional assess skin annually
Recommendations for reducing skin cancer in transplant recipients post-transplant
Allopurinol inhibits the metabolism of azathioprine, leading to potentially fatal myelosuppresion and severe GI adverse effects
How does allopurinol impact azathioprine?
Post-transplant lymphoproliferative disorder, infections, liver transplant
Belatacept boxed warnings
Epstein-Barr virus and tuberculosis
What test should be taken and reviewed before administering belatacept to avoid serious adverse events?
Atgam: aplastic anemia, graft-versus-host disease, transplant induction, organ rejection; Thymoglobulin: transplant induction, organ rejection
Antithymocyte globulin uses
Infusion-related reactions/cytokine release syndrome (fever, chills, pruritis, hypotension), infections, leukopenia, thrombocytopenia
Antithymocyte adverse effects
CBC with differential, signs and symptoms of infection, vital signs during administration
Antithymocyte globulin monitoring
To avoid infusion-related reactions (cytokine re;ease syndrome)
Why are premedication and appropriate infusion rates required when administering antithymocyte globulin?
Tacrolimus and cyclosporine
Which transplant drugs are associated with nephrotoxicity?
Modified: Grengraf Neoral; Nonmodified: Sandimmune
Oral capsule & solution branded cyclosporine formulations
Sandimmune
Intravenous solution branded cyclosporine formulation
Restasis
Opthalmic emulsion branded cyclosporine formulation
Calcineurin inhibitor (Tacrolimus) + Antiproliferative agents (Mycophenolate) ± Steroid (Prednisone)
First-line maintenance immunosuppression
Carbamazepine, phenobarbital, phenytoin; CYP3A4 or p-glycoprotein inducers can lead to graft rejection if cyclosporine levels are not monitored carefully
Which antiepileptic drugs can increase the risk of graft rejection?
Difference in absorption
What is the main reason CellCept and Myfortic are not interchangeable?
At steady state right before, or typically 30 minutes before, the next dose is due
When are trough levels drawn?
They weaken the immune system so that it will not attack the transplanted organ
What is the purpose of using cyclosporine and mycophenolate post transplant?
Tacrolimus and cyclosporine; Inhibitors, including grapefruit, will increase the drug concentration and increase toxicity; Inducers will decrease the drug concentration and could result in graft rejection
Which transplant drugs are CYP450 3A4 and P-gp substrates?
Risk of embryo-fetal toxicity
Mycophenolate Risk Evaluation and Mitigation Strategy (REMS)
MMR II, Rotarix, RotaTeq, Varivax, Vaxchora, Vivotif, FluMist, YF-VAX
Common live vaccines
Decreased metabolism to active form; Decreased serum concentration & clinical efficacy
What effect do inhibitors have on substrate prodrugs?
Amiodarone, azole antifungals, cobicistat, cyclosporine, grapefruit, macrolides, non-DHP CCBs, protease inhibitors
Common CYP450 inhibitors
Immunosuppressants can increase the risk of infections & cancer, stay consistent in how you take your medications, many immunosuppressats require monitoring of drug levels, multiple strengths of the same medications may be prescribed to you, immunosuppressants have many drug interactions, avoid live virus vaccines & inform your transplant provider before getting vaccinated
Key counseling points for immunosuppressants & transplant recipients
Azathioprine, Everolimus, Steroids, Tacrolimus, Cyclosporine
Drugs used for chronic maintenance in transplant recipients
Antithymocyte globulin
Which drug is used for induction (to prevent acute rejection), not maintenance?
Calcineurin inhibitors
Cyclosporine and tacrolimus drug class
Use the syringe provided by the manufacturer to measure the dose; NO NOT rinse the syringe before or after use; Use a compatible diluent (orange juice) at room temperature; Mix the dose and diluent thoroughly in a glas container. DO NOT administer from a plastic or styrofoam cup; Administer or drink immediately. Rinse the container with extra diluent to ensure the total dose is taken
Administration of cyclosporine oral solution
Electrolyte disturbances, hyperglycemia, hyperlipidemia, hypertension, infections, nephrotoxicity, neurotoxicity, QT prolongation
Adverse effects of cyclosporine & tacrolimus
Gingival hyperplasia, hirsutism (hair growth)
Cyclosporine-specific adverse effects
Alopecia (hair loss)
Tacrolimus-specific adverse effects
AB
AB blood can give blood to (Universal receiver)
AB, A, B, O
AB blood can receive blood from
A, AB
A blood can give blood to
A, O
A blood can receive blood from
B, AB
B blood can give blood to
B, O
B blood can receive blood from
AB, A, B, O
O blood can give blood to
O
O blood can receive blood from (Universal donor)
Optimize maintenance immunosuppression; High-dose corticosteroids followed by an oral steroid taper; Antithymocyte globulin for aggressive acute cellular rejection or steroid-resistant rejection
Treatment of acute cellular rejection